The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist

Glucagon-like peptide-1 (GLP-1) receptor agonists have been used extensively in the clinic and have an established safety profile in cardiovascular disease settings. For the treatment of peptide-secreting enteroendocrine cells, most research has focused on developing peptide multi-agonists as most o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Yun Kyung, La Lee, Yoo, Jung, Chang Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Lipidology and Atherosclerosis 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548186/
https://www.ncbi.nlm.nih.gov/pubmed/37800107
http://dx.doi.org/10.12997/jla.2023.12.3.213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548186/
https://www.ncbi.nlm.nih.gov/pubmed/37800107
http://dx.doi.org/10.12997/jla.2023.12.3.213

Ejemplares similares